All News

Durvalumab and Lynparza (olaparib) provided a response for patients in a small study.

Checkpoint inhibitors drastically changed the treatment landscape of urothelial carcinoma, and more changes are on the way.

CURE spoke with Eric Smith, M.D., Ph.D. about immunotherapy and other advances being made in multiple myeloma.

Believing and having faith during a seemingly impossible time in life can make all the difference.

One quirky trick to cut down on hair loss from chemo made me detest refrigerators for life!

On Feb. 21, we'll be co-hosting a tweet chat with Oncology Nursing News and Will2Love's Leslie R. Schover about sexual health and fertility after a cancer diagnosis. Join us at 9 p.m. EST with the hashtag #CureConnect

"THERE IS NO GOOD CARD FOR THIS: What to Say and Do When Life is Scary, Awful, and Unfair to People You Love" is a book that can help people use humor and empathy to be there for a loved one in need.

Now patients and caregivers can easily manage a lung cancer diagnosis with a mobile app.

After two years of writing for CURE, my story is suddenly as real as it gets.

The loss of hair during cancer treatment really can be devastating.

The Decipher test can be used to predict death and metastases in some patients with prostate cancer, according to findings that were recently presented.

Cancer quickly becomes your new, unwelcome, family business

Telephone-based smoking cessation counseling helped patients quit smoking, according to a recent study.

In a recent phase 3 trial, Lynparza improved progression-free survival in patients with BRCA-positive, HER2-negative breast cancer.

Rova-T proved to be safe and effective in patients with small cell lung cancer according to a recent study.

Breast cancer survivor shares her chemotherapy tips for patients who need chemotherapy.

After indulging a bit too much over the holidays, it's time to get back to the real world.

I know what scares me about metastatic cancer. Except when I don't...

A supplemental biologics license application was filed for Blincyto to be approved for certain patients with ALL.

Padeliporfin vascular-targeted photodynamic therapy may be a promising option for men with low-risk prostate cancer, according to the results of a recent study.

2016 was an exciting year for non-small cell lung cancer, and more advances are expected for 2017.

Recording personal thoughts during cancer can be a helpful way to process feelings.

Please, If I could just complain, I mean explain, this whole after-treatment thing.

Two studies examine the importance of knowing if you have dense breast tissue.

STARTRK-2 trial is a currently enrolling trial to test the efficacy and safety of the agent entrectinib which targets 5 abnormalities across a number of cancer sites.

I was pretending life was great after my cancer treatment ended. Meanwhile, I was living in a cancer coma.

Being a widow for two years means dealing with the guilt, independence and loneliness that comes with it.